共 104 条
[21]
Novelli V(2003) associated diseases Clin Infect Dis 37 S188-224
[22]
Costoli V(1998)Combination and Sequential Antifungal Therapy for Invasive Aspergillosis: Review of Published Adv Pharmacol 44 343-500
[23]
Gerson SI(1998) and Clin Infect Dis 26 1383-1390
[24]
Talbot GH(1997) Interactions and 6281 Clinical Cases from 1966 to 2001 Clin Infect Dis. 24 635-641
[25]
Lusk E(1994)Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development Am J Med 97 135-144
[26]
Gefter WB(1998)Amphotericin B lipid complex in patients with invasive fungal infections: analysis of safety and efficacy in 556 patients Antimicrob Agents Chemother 42 899-902
[27]
Albelda SM(2000)Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis Clin Infect Dis 31 1155-1163
[28]
Talbot GH(1998)NIAID Mycoses Study Group multicenter trial of oral itraconazole therapy for invasive aspergillosis Pediatr Infect Dis 17 146-148
[29]
Taccone A(2002)Comparison of Fungisone, Amphotec, Ambisome, arid abelcet for treatment of systemic murine cryptococcosis N Eng J Med 347 408-415
[30]
Occhi M(2002)A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia Pediatr Infect Dis J 21 240-248